Scientist profiles A-F
SRI Profiles
A
Adhikari, NeillAdler Nevo, GiliAlam, AsimAlam, Fahad
Alhusayen, RaedAlter, David
Amaral, AndreAnderson, MicheleAndrews, David W.Angle, PamelaAntonyshyn, OlehAsztalos, ElizabethAtzema, ClareAubert, IsabelleAustin, PeterAviv, RichardAwad, Imad T.B
Barbera, LisaBarnes, Elizabeth (Toni)Barrett, JonBastarrika, Gorka
Bell, MaryBerinstein, NeilBerndl, AnneBerry, Scott
Bhatti, JunaidBinhammer, Paul
Birt, CatherineBjarnason, GeorgBlack, SandraBlakely, JohnBondy, SusanBoulos, Mark I.Brenneman, FredBronskill, MichaelBronskill, SusanBuckstein, RenaBurns, PeterC
Callum, JeannieCarlyle, JamesCartotto, RobertCastel, Saulo
Chan, Adrienne K.Chan, Kelvin Kar-WingChapman, Martin
Chen, Joyce L.Chenkin, JordanCheung, AmyCheung, MatthewCheung, Patrick
Chin, LeeChoi, StephenChow, EdwardChristakis, GeorgeChu, William
Chung, HansChurch, Paige
Coburn, NatalieCohen, CaroleCole, DavidCourtney, BrianCovens, AllanCrystal, EugeneCunningham, CharlesCuthbertson, Brian H.Czarnota, GregoryD
da Costa, Leodanteda Luz, Luis TeodoroDabdoub, AlainDale, CraigDaneman, NickDavid, ElizabethDeAngelis, Carlo
Démoré, ChristineDimitrijevic, AndrewDueck, AndrewE
Earle, CraigEisen, Andrea
Emmenegger, UrbanEnepekides, Danny
Etchells, EdF
Feinstein, AnthonyFialkov, Jeffrey
Filmus, JorgeFinkelstein, JoelFord, Michael
Foster, StuartFowler, RobertFremes, StephenFung, Vera
Spotlight on
Dr. David Andrews
Andrews is the director of Biological Sciences at SRI. One of his areas of research is apoptosis, otherwise known as programmed cell death. It is the Bcl-2 family of proteins—which include Bax and Bak—that he is specifically investigating.
Along with colleagues, Andrews recently discovered small molecules that prevent Bax and Bak from binding, a critical step in the execution of apoptosis. This could lead to the development of a drug that temporarily keeps select cells alive while treatment for various diseases is administered. The finding was presented in Cell Chemical Biology.
